Erin VanDyke on Why They Do In-person Site Visits for NBCA Centers of Excellence Designation!
Erin VanDyke, Vice President of NBCA Centers of Excellence, shared on LinkedIn:
”“Why do you do in-person site visits for COE designation?”
It’s a question I get asked often — and honestly, it’s one of my favorite parts of the process to talk about.
At National Blood Clot Alliance, we believe that achieving a Center of Excellence designation should reflect more than the strength of one service line.
It should represent a hospital-wide commitment to improving every aspect of VTE prevention, diagnosis, treatment, follow-up, and community awareness.
That’s why the site visit matters so much.
Being there in person allows us to see and feel the culture — how the team communicates, how barriers are approached, and how deeply VTE awareness is woven into the organization.
It gives us a chance to meet the people who make the work happen — from the physicians and APPs to the nurses, pharmacists, and administrators — and to have honest conversations about what’s working, what’s not, and where we can help.
The goal isn’t just to evaluate readiness for designation; it’s to partner in building something sustainable.
To use objective data to refine pathways, strengthen careflows, and ultimately deliver the best possible outcomes for patients.
Because for us, the COE designation isn’t a finish line — it’s the beginning of an ongoing collaboration to grow, evolve, and raise the bar for VTE care together.”

Stay updated with Hemostasis Today.
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’
-
Jul 7, 2026, 20:59William Aird: An Unlucky Turn Into the Renal Artery
-
Jul 7, 2026, 20:58Chokri Ben Lamine: The Two-Hit Model of TRALI
-
Jul 7, 2026, 20:57New Issue of Blood Out Now – Blood Journals Portfolio